dihydrotetrabenazine has been researched along with Basal Ganglia Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, KA; Gilman, S; Jewett, DM; Junck, L; Kilbourn, MR; Koeppe, RA; Lee, LC; Little, R; Lohman, M; Martorello, S; Vander Borght, TM | 1 |
1 other study(ies) available for dihydrotetrabenazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Biological Transport; Cerebellar Diseases; Corpus Striatum; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Olivopontocerebellar Atrophies; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1996 |